These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12638138)

  • 21. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
    Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I; Colclough A; Northwood J
    Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and safety of twice-daily administration of CTDR].
    Ogata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():98. PubMed ID: 12638156
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study.
    Reinert RR; Simic S; Al-Lahham A; Reinert S; Lemperle M; Lütticken R
    J Clin Microbiol; 2001 Mar; 39(3):1187-9. PubMed ID: 11230456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of faropenem against infections in pediatric fields].
    Sunakawa K; Satoh Y; Iwata S; Terashima I; Meguro H; Kusumoto Y; Kato T; Akita H; Goshima T; Yokota T; Toyonaga Y; Ishihara T; Kanemura H; Iwai N; Nakamura H; Nakashima M
    Jpn J Antibiot; 1997 Sep; 50(9):739-55. PubMed ID: 9394235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pneumococcal and chlamydial infections in a closed community].
    Vishniakova LA; Zhogolev SD; Moshkevich IR
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (4):60-4. PubMed ID: 11569268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study].
    Tudose C; Bumbăcea D; Bogdan M;
    Pneumologia; 2011; 60(1):30-5. PubMed ID: 21548198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The microbiologist's point of view].
    Gutmann L
    Presse Med; 2002 Nov; 31(37 Pt 2):S4-5. PubMed ID: 12489324
    [No Abstract]   [Full Text] [Related]  

  • 29. [Epidemiological study of pneumococcal infection and Haemophilus influenzae infection].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():4-10. PubMed ID: 12638134
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mode of transmission and natural course of pneumococcal infection].
    Ito M
    Jpn J Antibiot; 2001 May; 54 Suppl B():108. PubMed ID: 12638162
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
    Watanuki Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():502-7. PubMed ID: 17455671
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae.
    Drago L; Nicola L; Rodighiero V; Larosa M; Mattina R; De Vecchi E
    J Antimicrob Chemother; 2011 Apr; 66(4):845-9. PubMed ID: 21393187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins.
    Hedrick JA
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):15-21. PubMed ID: 20014898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiological study of pneumococcal infections and Haemophilus influenzae infections in the last three years].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():72-9. PubMed ID: 12638146
    [No Abstract]   [Full Text] [Related]  

  • 35. Ciprofloxacin vs. the pneumococcus.
    Karcic AA; Khan FA
    Chest; 2000 Oct; 118(4):1226-7. PubMed ID: 11035706
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
    Nagy E; Marton A; Hajdú E
    Acta Microbiol Immunol Hung; 2003; 50(2-3):119-24. PubMed ID: 12894483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily.
    Bowlware KL; McCracken GH; Lozano-Hernandez J; Ghaffar F
    Pediatr Infect Dis J; 2006 Mar; 25(3):208-10. PubMed ID: 16511381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and bacteriological studies of Streptococcus pneumoniae. Yearly changes in isolation frequencies from clinical specimens, serotype distributions and drug susceptibilities, especially those of beta-lactam-resistant strains].
    Oguri T
    Jpn J Antibiot; 1986 Mar; 39(3):783-806. PubMed ID: 3735669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy.
    Marchese A; Ardito F; Fadda G; Fontana R; Lo Cascio G; Nicoletti G; Speciale AM; Schito GC
    Int J Antimicrob Agents; 2005 Jul; 26(1):8-12. PubMed ID: 15967638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
    Cantón R; Unal S; Farrell DJ
    Int J Antimicrob Agents; 2007 Dec; 30(6):546-50. PubMed ID: 17931834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.